| 期 |
栏目 |
标题 |
文件 |
| 卷 19, 编号 3 (2021) |
Articles |
Sorcin as a potential target in molecular diagnostics and targeted therapy of lung cancer |
|
| 卷 20, 编号 3 (2022) |
Articles |
Sarcoidosis: molecular markers and targets for targeted diagnosis and therapy |
|
| 卷 21, 编号 1 (2023) |
Original research |
The effect of tuberculosis on the course of lung carcinoma in the experiment |
|
| 卷 20, 编号 6 (2022) |
Reviews |
Signaling molecules of tumor transformation in tuberculosis |
|
| 卷 20, 编号 6 (2022) |
Original research |
Possibilities of application of allogenic tissue engineering products in the experimental urinary bladder reconstruction |
|
| 卷 21, 编号 2 (2023) |
Original research |
The effect of antitumor drugs on the course of tuberculosis in the experiment |
|
| 卷 21, 编号 5 (2023) |
Reviews |
Connexins: role in intercellular interactions in normal and pathological conditions of the respiratory system |
|
| 卷 21, 编号 5 (2023) |
Original research |
The use of mesenchymal stem cells in the complex treatment of drug-resistant kidney tuberculosis (experimental study with morphological control) |
|
| 卷 21, 编号 5 (2023) |
Original research |
The role of signaling molecules – factors of migration and adhesion of lymphocytes in the pathomorphosis of pulmonary tuberculoma |
|
| 卷 21, 编号 6 (2023) |
Reviews |
Experimental replacement of various bladder volumes with allogeneic tissue-engineered constructions |
|
| 卷 22, 编号 1 (2024) |
Original research |
Effectiveness and safety of carboplatin-containing antitumor therapy regimens in a model of coexistance of lung carcinoma and tuberculosis |
|
| 卷 22, 编号 2 (2024) |
Original research |
Biological model of lung cancer combination and tuberculosis: development for preclinical study of rational combinations of targeted antitumor and antituberculosis therapy |
|
